Controlling the behavioural problems of Alzheimer's patients is possible, according to new data.
The Irish Medical Times reports that findings published in the International Journal of Geriatric psychiatry also show the emergence of new behavioural problems can be delayed by drug treatments.
Conducted by Canadian Professor Serge Gauthier, the study reveals that Ebixa can improve specific behavioural symptoms in patients and delay the emergence of symptoms in others, the news provider states.
"The result is that the use of Ebixa may allow clinicians to avoid the use of antipsychotics in treating behavioural symptoms of moderate to severe Alzheimer's disease," it adds.
According to the news source, concerns have been raised over the safety of atypical antipsychotics due to associations with cognitive decline, extrapyramidal symptoms, lowered blood pressure, sedation and the raised mortality risk.
Last week the chief executive of the Alzheimer's Society said antipsychotic drugs should be given to the elderly as a last resort.
Neil Hunt told the Telegraph that over-prescription of the drugs breaches human rights.
Please click here to find a care home for elderly care.